ICUI

ICU Medical, Inc. [ICUI] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ICUI Stock Summary

Top 10 Correlated ETFs

ICUI


Top 10 Correlated Stocks

ICUI


In the News

08:30 28 Mar 2024 ICUI

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum

SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical's presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 20, 2024.

05:15 28 Mar 2024 ICUI

ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference

SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. ICU Medical's presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, March 4, 2024.

07:21 28 Mar 2024 ICUI

ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates

ICU Medical (ICUI) came out with quarterly earnings of $1.57 per share, beating the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.60 per share a year ago.

09:25 28 Mar 2024 ICUI

2 Stocks in Focus as New Analysts Initiate Coverage

The recent surge in analyst coverage for stocks such as ICU Medical (ICUI) and Ardmore Shipping (ASC) indicates the potential for significant price appreciation in the near term.

08:30 28 Mar 2024 ICUI

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call

SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call.

05:09 28 Mar 2024 ICUI

ICU Medical: Who Is Coming To The Rescue?

ICU Medical, Inc. has faced disappointment and poor performance due to previous acquisitions and lower-quality business activities. The company's recent acquisition of Smiths Medical Business did not meet sales expectations, leading to a shortfall in earnings. ICU Medical's stock has declined significantly, and its leverage ratios are high, causing concerns amidst sales declines of the business.

08:05 28 Mar 2024 ICUI

ICU Medical, Inc. (ICUI) Q3 2023 Earnings Call Transcript

ICU Medical, Inc. (NASDAQ:ICUI ) Q3 2023 Results Conference Call November 6, 2023 4:30 PM ET Company Participants John Mills - Managing Partner at ICR Vivek Jain - Chief Executive Officer and Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Larry Solow - CJS Securities Jayson Bedford - Raymond James Operator Good afternoon. And welcome to the ICU Medical Inc. Third Quarter 2023 Earnings Conference Call [Operator Instructions].

08:30 28 Mar 2024 ICUI

ICU Medical Announces Time of Third Quarter 2023 Earnings Conference Call

SAN CLEMENTE, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call.

11:17 28 Mar 2024 ICUI

ICU Medical's (ICUI) Plum Duo With Safety Shield Gets 510(k) Nod

The Plum Duo infusion pump represents the latest addition to ICU Medical's (ICUI) advanced lineup of infusion devices.

05:36 28 Mar 2024 ICUI

ICU Medical: Continued Disappointments

ICU Medical's deal with Smiths Medical is underperforming, following a previous troubled deal with Hospira Infusion Systems. Shares have fallen by 50% over the past two years, as the company's outlook is uncertain. The business is facing quality issues and higher interest costs, and its leverage is still high.

ICUI Financial details

Company Rating
Buy
Market Cap
2.37B
Income
-29.66M
Revenue
2.26B
Book val./share
87.96
Cash/share
10.55
Dividend
-
Dividend %
-
Employees
14K
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-82.58
Forward P/E
102.89
PEG
13.66
P/S
1.03
P/B
1.1
P/C
9.75
P/FCF
-184.88
Quick Ratio
0.78
Current Ratio
2.63
Debt / Equity
0.78
LT Debt / Equity
0.74
-
-
EPS (TTM)
-1.23
EPS next Y
1
EPS next Q
0.82
EPS this Y
-60.45%
EPS next Y
-181.03%
EPS next 5Y
-823.58%
EPS last 5Y
NAN%
Revenue last 5Y
12.27%
Revenue Q/Q
6.27%
EPS Q/Q
-336.67%
-
-
-
-
SMA20
-6.76%
SMA50
3.85%
SMA100
-2.39%
Inst Own
55.27%
Inst Trans
0.6%
ROA
-1%
ROE
-1%
ROC
-
Gross Margin
33%
Oper. Margin
-
Profit Margin
-1%
Payout
-
Shs Outstand
24.14M
Shs Float
21.01M
-
-
-
-
Target Price
190
52W Range
78.28-212.43
52W High
-51.47%
52W Low
+31.91%
RSI
54.65
Rel Volume
0.77
Avg Volume
264.69K
Volume
204.79K
Perf Week
3.75%
Perf Month
3.99%
Perf Quarter
-13.19%
Perf Half Y
-11.35%
-
-
-
-
Beta
0.699
-
-
Volatility
1.79%, 3.72%
Prev Close
2.11%
Price
102.89
Change
4.49%

ICUI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
61.3860.7962.0795.5393.76
Net income per share
4.94.164.86-3.11-1.23
Operating cash flow per share
4.9410.6512.62-2.66.9
Free cash flow per share
-0.25.858.79-6.763.01
Cash per share
14.1919.6526.758.9210.57
Book value per share
66.7671.8576.2187.5688.14
Tangible book value per share
5560.8465.28-14.33-9.12
Share holders equity per share
66.7671.8576.2187.5688.14
Interest debt per share
1.782.582.1672.0574.1
Market cap
3.86B4.48B5.03B3.76B2.4B
Enterprise value
3.63B4.14B4.53B5.2B3.85B
P/E ratio
38.2151.6248.8-50.6-81.03
Price to sales ratio
3.053.533.821.651.06
POCF ratio
37.8720.1318.81-60.514.46
PFCF ratio
-936.4636.6527.01-23.2833.13
P/B Ratio
2.82.993.111.81.13
PTB ratio
2.82.993.111.81.13
EV to sales
2.873.263.442.281.71
Enterprise value over EBITDA
24.4430.331.8522.9813.27
EV to operating cash flow
35.5918.5916.91-83.7523.18
EV to free cash flow
-880.0833.8424.28-32.2353.13
Earnings yield
0.030.020.02-0.02-0.01
Free cash flow yield
00.030.04-0.040.03
Debt to equity
0.030.030.030.790.78
Debt to assets
0.020.030.020.370.38
Net debt to EBITDA
-1.57-2.52-3.576.385
Current ratio
3.554.715.132.52.53
Interest coverage
115.1523.8561.05-0.130.29
Income quality
1.012.562.590.84-5.6
Dividend Yield
00000
Payout ratio
000.01-0.15-0.32
Sales general and administrative to revenue
0.220000
Research and developement to revenue
0.040.030.040.040.04
Intangibles to total assets
0.140.130.120.540.54
Capex to operating cash flow
-1.04-0.45-0.31.6-0.56
Capex to revenue
-0.08-0.08-0.06-0.04-0.04
Capex to depreciation
-1.24-1.06-0.9-0.42-0.37
Stock based compensation to revenue
0.020.020.020.020.02
Graham number
85.7781.9691.3278.3149.41
ROIC
0.040.020.0300
Return on tangible assets
0.070.060.06-0.04-0.01
Graham Net
14.4419.1324.86-71.16-63.19
Working capital
633.73M725.29M829.03M740.64M737.77M
Tangible asset value
1.13B1.27B1.38B-342.1M-219.62M
Net current asset value
567.06M659.35M765.1M-1.19B-1.04B
Invested capital
0.030.030.030.790.78
Average receivables
199.33M163.16M114.99M163.81M193.02M
Average payables
124.55M100.25M76.5M148.52M182.97M
Average inventory
324.4M326.28M302.58M493.12M702.68M
Days sales outstanding
58.2935.6429.3635.4926.55
Days payables outstanding
59.132.435.949.8135.35
Days of inventory on hand
155.15142128.44160.56167.15
Receivables turnover
6.2610.2412.4310.2813.75
Payables turnover
6.1811.2610.177.3310.32
Inventory turnover
2.352.572.842.272.18
ROE
0.070.060.06-0.04-0.01
Capex per share
-5.14-4.8-3.83-4.16-3.89

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
24.123.7622.8222.9324.36
Net income per share
-0.65-0.41-0.410.3-0.71
Operating cash flow per share
-0.071.72-0.061.463.78
Free cash flow per share
-1.071.02-0.910.442.46
Cash per share
8.889.378.218.2510.55
Book value per share
87.1287.7787.8486.9587.96
Tangible book value per share
-14.26-13.37-11.61-9.84-9.1
Share holders equity per share
87.1287.7787.8486.9587.96
Interest debt per share
69.7669.7769.1768.7569.71
Market cap
3.78B3.95B4.29B2.87B2.41B
Enterprise value
5.22B5.37B5.74B4.31B3.86B
P/E ratio
-60.79-100.59-107.9699.2-35.1
Price to sales ratio
6.546.947.815.194.09
POCF ratio
-2.21K95.72-2.91K81.6826.38
PFCF ratio
-146.62161.08-196.09270.8640.6
P/B Ratio
1.811.882.031.371.13
PTB ratio
1.811.882.031.371.13
EV to sales
9.039.4510.447.796.56
Enterprise value over EBITDA
704.3771.4876.3462.67101.71
EV to operating cash flow
-3.05K130.3-3.89K122.5742.27
EV to free cash flow
-202.69219.28-262.15406.4665.07
Earnings yield
0000-0.01
Free cash flow yield
-0.010.01-0.0100.02
Debt to equity
0.790.780.780.780.78
Debt to assets
0.370.370.370.370.38
Net debt to EBITDA
194.8418.9719.2420.9138.24
Current ratio
2.52.622.572.632.53
Interest coverage
-2.460.860.110.95-0.58
Income quality
0.11-4.20.154.86-5.32
Dividend Yield
00000
Payout ratio
-0.7-0.86-0.180.18-0.67
Sales general and administrative to revenue
00000
Research and developement to revenue
0.040.030.040.040.04
Intangibles to total assets
0.540.540.540.530.54
Capex to operating cash flow
14.06-0.4113.84-0.7-0.35
Capex to revenue
-0.04-0.03-0.04-0.04-0.05
Capex to depreciation
-0.42-0.3-0.35-0.42-0.56
Stock based compensation to revenue
0.010.020.020.020.02
Graham number
35.6328.4528.5624.2237.49
ROIC
-0.0100-0.010
Return on tangible assets
-0.01000-0.01
Graham Net
-70.8-69.68-68.17-65.4-63.07
Working capital
740.64M750.85M760.86M755.37M737.77M
Tangible asset value
-342.1M-320.01M-279.49M-237.38M-219.62M
Net current asset value
-1.19B-1.16B-1.1B-1.06B-1.04B
Invested capital
0.790.780.780.780.78
Average receivables
219.97M180.59M150.84M162.01M163.06M
Average payables
210.47M201.16M176.74M158.17M149.66M
Average inventory
660.64M721.99M761.62M767.45M734.49M
Days sales outstanding
34.5222.0726.5826.3225.15
Days payables outstanding
48.2144.5542.1236.3731.39
Days of inventory on hand
155.41178.75195.46185.08148.41
Receivables turnover
2.614.083.393.423.58
Payables turnover
1.872.022.142.472.87
Inventory turnover
0.580.50.460.490.61
ROE
-0.01000-0.01
Capex per share
-1-0.7-0.85-1.02-1.32

ICUI Frequently Asked Questions

What is ICU Medical, Inc. stock symbol ?

ICU Medical, Inc. is a US stock , located in San clemente of Ca and trading under the symbol ICUI

Is ICU Medical, Inc. buy or a sell ?

3 stock analysts have 3 predictions with a medium analyst target price of $211. The lowest prediction is $190 and the highest is $235

What is ICUI stock prediction ?

What is ICU Medical, Inc. stock quote today ?

ICU Medical, Inc. stock price is $102.89 today.

Is ICU Medical, Inc. stock public?

Yes, ICU Medical, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap